on behalf of the UK Intensive Care Society Extra-corporeal membrane oxygenation (ECMO) is used as rescue therapy for adults with severe acute respiratory failure. We aimed to determine the views of intensive care clinicians on regionalisation of critical care services and on the development of adult ECMO services in the UK. A survey was undertaken of all members of the UK Intensive Care Society; 2,133 participants were invited to complete the survey and 691 responded (32.7%). Among respondents, 65% believed that adult ECMO services should be expanded, 42.5% agreed that intensive care services in the UK should be regionalised, while 63.8% agreed the UK should develop regional ventilatory care centres including ECMO services. Experience during H1N1 influenza pandemics was the factor respondents most frequently identified as driving ECMO expansion (61.1%). Of respondents, 60.1% believe that an expanded ECMO service should be provided in 5-10 supraregional centres. Patient safety, resources, guidelines and transportation of sick patients were also seen as important issues. We conclude that there is a reasonable level of support for regionalisation of intensive care services and for expansion in ECMO services for adults with severe acute respiratory failure in the UK. Clinicians support appropriate funding, investment in transport services and the development of national guidelines.
Introduction
Increased regionalisation of intensive care services in the UK could have advantages, including improved outcome from critical illness. [1] [2] [3] [4] However, there are many potential disadvantages, including considerable challenges related to safe inter-hospital transfer of critically ill patients and increased distance between patients and families.
Extra-corporeal membrane oxygenation (ECMO) has been used sporadically as rescue therapy for adults with severe acute respiratory failure since the 1970s, despite early randomised controlled trials failing to demonstrate an improvement in outcome. 5 The CESAR trial, 6 the first randomised, controlled trial to examine the role of ECMO for adults in the era of lungprotective ventilatory strategies, suggested that the use of an ECMO-based management protocol significantly improved outcome in a cost-effective manner. In addition, ECMO was used extensively during the 2009 H1N1 influenza pandemic in patients with refractory hypoxaemia. 7, 8 In many countries, the demand for ECMO considerably exceeded the available capacity of the existing ECMO centres and ECMO was provided at a number of different sites as emergency rescue therapy. The UK Department of Health Swine Flu Critical Care Clinical Group recommended further assessment of the long-term capacity needed for adult ECMO. 9 In late 2010, there was a further peak in severe acute respiratory failure associated with H1N1 influenza 10 and ECMO was provided at a number of designated surge centres throughout the UK. Following the publication of the CESAR trial, and as identified in the accompanying editorial, 11 opinion has been divided as to whether CESAR has confirmed that ECMO is a safe and effective management strategy in patients with severe acute respiratory failure, or whether its limitations prevent such a conclusion being drawn. The opinion of UK intensive care clinicians regarding regionalisation of intensive care services and the future role of ECMO for adults with severe acute respiratory failure is not known. Our aim was to seek the opinions of UK intensive care clinicians about the regionalisation of adult intensive care services, the future role of ECMO for adults with severe respiratory failure and, if expansion of ECMO provision is warranted, how this should be implemented into practice safely.
Methods

Survey design
An internet-based survey was distributed by email to assess UK clinicians' attitudes towards regionalisation of intensive care
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services and their opinions regarding the future of ECMO services in the UK. We included questions regarding the respondent' s job title, size of hospital, type of unit and their previous experience of ECMO. We asked about beliefs with regard to regionalisation of adult intensive care services. Questions regarding ECMO covered three areas: 1. Beliefs about the current evidence base for ECMO in severe acute respiratory failure, including perceptions about benefits and harm.
Respondents' beliefs about whether ECMO services should
be expanded in the UK. 3. How an expanded ECMO service should be delivered.
Item generation was performed based on the key domains of interest related to the study aims and from an existing publication on regionalisation of intensive care services. 12 Item reduction was performed mainly with the overlap between regionalisation of adult intensive care services and ventilator care centres. Ordinal responses (Likert scales) were used as responses for most questions to elicit respondents' level of agreement, ranging from 'strongly agree' to 'strongly disagree. ' We treated neutral responses as indicative of an indeterminate response (ie not having a belief on the matter rather than indicating a middle-rank response). We performed pre-testing to test clarity and comprehension, as well as sensibility testing to test comprehensiveness, clarity and face validity of the questionnaire, on five intensive care specialists, and modified the survey based on this. We did not perform reliability testing. 13 Advice was sought from the North of Scotland Research Ethics service, who concluded that the survey represented service evaluation and thus that research ethics committee approval was not required.
Subjects
We identified subjects for our survey from the Intensive Care Society (ICS) membership database, which had 2,655 members of whom 2,113 had functioning email addresses. We included all ICS members as our target respondents. This was identified as the most extensive, complete and up-to-date database of intensive care clinicians in the UK and the only one which included consultant and trainee medical staff as well as intensive care nurses and allied health professionals.
Distribution
An email was sent to all members of the ICS, inviting them to participate in the internet-based survey. All potential respondents were sent a unique link that allowed them to complete the survey only once, which was not transferrable to other potential respondents. After three weeks, a further reminder email was sent to all potential respondents. The survey was conducted using the SurveyMonkey TM programme.
Data collection and presentation
Data was collected from November 2010 until February 2011. Following closure of the survey to new respondents, results were downloaded in Microsoft Excel TM format from the SurveyMonkey TM programme. Number and frequency responses for each question are presented in the Appendix. In the text, we present the percentage agreeing (combining strongly agree and agree categories) and disagreeing (combining disagree and strongly disagree categories) and we do not present the numbers who were neutral on the question. 
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Analysis
Data is presented as numbers and percentages or frequencies as appropriate. Statistical analysis of correlations was performed using chi-square tests.
Results Responses
There were 2,655 email invitations distributed to email addresses held by the ICS for their members. Of these, 542 were distributed to email addresses that were no longer active, making the denominator 2,113. A total of 691 participants completed the survey, giving an overall response rate of 32.7%. Table 1 shows the baseline characteristics of the respondents with regard to their job descriptions.
Regionalisation
Full responses to questions relating to regionalisation of adult ICU services are presented in Figure 1 . In summary, 42.5% of respondents agreed and 41.4% disagreed, that 'ICU services in the UK should be regionalised.' Of all respondents, 63.8% agreed that 'the UK should develop regional ventilatory care centres.'
Beliefs about the evidence
Beliefs about the evidence base for ECMO are presented in Figure 2 . In summary, 38.1% agreed the evidence base supports ECMO and 27.5% disagreed. Of all respondents, 34.4% agreed the 'results of the CESAR trial supports the use of ECMO in ventilated adults with severe acute respiratory failure' and 30.8% disagreed. A minority, 18.1% of respondents agreed that 'the results of the CESAR trial showed ECMO was costeffective' and 30.8% disagreed. Most respondents, 72%, agreed that 'further clinical trials evaluating the effectiveness and costeffectiveness of ECMO are required prior to expansion of these services.'
Requirement for expansion of ECMO services
In this survey, 65.0% of respondents believe there is a requirement for the expansion of adult ECMO services in the UK and 64.8% of respondents believe their unit is a potential ECMO unit; 65.2% of respondents who have previous ECMO experience believe there is a requirement for expansion or services. Table 2 presents data on levels of agreement with the effects of an expanded adult ECMO service in the UK.
Beliefs about the outcome benefits from ECMO
Factors driving ECMO expansion
Delivery of an expanded ECMO service
Correlates
Respondents who agreed that 'the results of the CESAR trial support the use of ECMO in ventilated adults with severe hypoxic respiratory failure' (182/238; 76.5%) also believe the results of 'the CESAR trial are a factor driving ECMO expansion' compared to 52/277 (18.8%) who did not (p<0.001). Of the 263 respondents who agreed that 'the currently available evidence base supports the expansion of ECMO services,' 238 (90.4%) also believe that 'ECMO services in the UK should be expanded' compared to 47 of the 190 (24.7%) respondents who disagree (p<0.001).
Of respondents who worked in tertiary centres compared to non-tertiary centres (small and large district general hospitals), more agreed (197/289 (68.1%) vs 92/281 (32.7%); p<0.001) with regionalisation of ICU services. More also agreed (249/308 (80.8%) vs 186/268 (69.4%); p=0.001) with regionalisation of ventilator centres. More agreed that regionalisation of ICU services would improve outcome (190/277 (68.6%) vs 82/247 (33.2%); p<0.001) and that regional ventilatory centres would improve patient outcomes (220/284 (77.5%) vs 140/231 (60.6%); p<0.001). Table 2 Level of agreement with the effects of an expanded adult ECMO service in the UK.
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In respondents who worked in potential ECMO centres compared to non-ECMO centres, more agreed (157/235 (66.8%) vs 10/38 (26.3%); p<0.001) with regionalisation of ICU services, and more agreed (198/249 (78.3%) vs 22/33 (66.6%)(p=0.09) with regionalisation of ventilator centres. More also agreed that regionalisation of ICU services would improve outcome (156/231 (67.5%) vs 8/33 (24.2%); p<0.001) and that regional ventilator centres (179/236 (75.8%) vs 15/27 (55.5%); p=0.02) would improve patient outcomes.
In respondents who had no experience of ECMO compared to those who had experience of using ECMO or who had worked in a potential ECMO centre, more agreed that the current evidence base supports the use of ECMO (37/53 (69.8%) vs (226/400 (56.5%), p=0.07); and more agreed that the results of the CESAR trial support the use of ECMO in this group (36/50 (72.0%) vs 202/415 (48.7%), p=0.002).
Discussion
To our knowledge, this is the first survey seeking the opinion of clinicians on the future role of ECMO for adults with severe hypoxic respiratory failure. This internet-based survey was distributed to all members of the UK ICS, which is not a complete database of all UK clinicians with an interest in intensive care medicine, but is the most comprehensive database of individuals available to guide a survey.
Regionalisation of ICU services
Regionalisation of intensive care services is a complex issue. Several studies have demonstrated that a high volume of admissions is associated with improved outcome in cohorts of general critically ill patients, 1,2 in those requiring mechanical ventilation 3 and in patients with severe sepsis. 4 In addition, larger units are associated with economies of scale and potentially result in reduced costs for healthcare providers. 14 However, other authors have identified that severity of illness, as assessed by APACHE II scores, may be negatively correlated with volume, 15 highlighting the importance of ensuring adequate control for severity of illness in such studies. Clinicians' attitudes to regionalisation may be influenced by a great number of factors, not least whether their unit would be a net donor or receiver of patients in a regionalised system. The respondents were evenly split on the question of whether ICU services should be regionalised. A minority of respondents agree that regionalisation will improve intensive care outcomes in the UK, with two-thirds of these currently working in tertiary centres. This suggests that belief in regionalisation is not confined to those working in centres that would receive patients in a regionalised system. It compares to just over half of respondents in a survey of US intensive care physicians who believed that regionalisation of intensive care services would improve patient outcome. 12
Regionalisation of ventilatory care including ECMO
Just under two-thirds of respondents are in favour of regionalisation of ventilatory care services for adults with severe acute respiratory failure. Such units would deliver strategies such as advanced ventilatory manoeuvres, high frequency oscillatory ventilation, etc. Only half (52.8%) believe that the development of such centres will improve outcome from severe acute respiratory failure. It is interesting to reflect on why a larger number of respondents are in favour of regionalisation when they do not see a benefit in outcome.
Despite the high numbers who believe in regionalisation of ventilator care centres, more than twothirds of respondents do not believe that transporting critically hypoxaemic patients is safe. If there is to be a move towards regionalisation of care of these patients, this will need to be combined with the development of appropriate transport services. Clinicians also support national guidelines on the topic to guide practice. Our respondents suggest that patients and families would generally support transfer to ECMO units, regardless of their location. The views of patients and their families would have to be considered to make high-quality decisions about future provision of care. Clearly, key stakeholders need to consider all of these issues when planning further developments.
The evidence for ECMO
The most important factor felt to be driving ECMO expansion is experience of its use during the H1N1 influenza pandemic. Less than half of respondents felt the results of the CESAR trial were a factor driving ECMO expansion. In this study, only 75% of those randomised to the ECMO-based management strategy received ECMO. It has been suggested 11, 16 that some of the benefit identified from ECMO may have been attributable not to ECMO itself, but to the non-ECMO strategies employed in a unit with a wealth of experience in managing adults with severe acute respiratory failure. A recent UK propensitymatched analysis of influenza patients treated with ECMO versus control suggests a marked improvement in outcome in the ECMO treated patients. 17 These results were published after completion of the current survey.
Over half (51.6%) of our respondents believe severe acute respiratory failure can be safely managed without ECMO. Nearly three quarters (71.9%) of respondents believe that further clinical trials are needed in this field. It is not clear why this is the case when 65% of respondents support expansion of ECMO services at present; although if 64.8% of respondents see their unit as a potential ECMO unit this may be driven by personal enthusiasm. Whether there is any appetite to repeat the CESAR study is uncertain, but it could be argued that it should act as a pilot study for a larger effectiveness study, powered to study mortality. The control group for such a study should be patients managed in a regional ventilator unit using conventional respiratory support, excluding ECMO.
Health economic issues
In the CESAR trial, the cost per quality-adjusted life year (QALY) for ECMO was £19,252. This compares favourably with other health technologies and is below the UK threshold for cost-effectiveness. 18 However, only 18.1% of respondents to our survey believe the CESAR trial shows that ECMO is actually cost-effective. This may reflect respondents' lack of certainty of the interpretation of cost-effectiveness analyses, or a belief that cost-effectiveness results were less robust than the effectiveness outcome. Any future large-scale ECMO study would require a well-developed cost-effectiveness analysis as an integral part of the study.
Appropriate funding for the development of ECMO centres is clearly an important issue for respondents to our survey. The majority believe appropriate funding both for ECMO and the for inter-hospital transfers should be in place prior to expansion.
Correlates
In this survey, the majority of clinicians who believed that the current evidence base supports ECMO thought that ECMO services should be expanded. Only a minority of those who did not believe the currently available evidence supports ECMO believed that services should be expanded. It is interesting to note that a considerably greater proportion of those working in tertiary units, as opposed to district general hospitals, believed that ICU services should be regionalised and believed that regionalisation would improve outcome. Those working in tertiary units may well believe they would become net importers of patients in a regionalised system of intensive care, and those working in district general hospitals may believe they would be net exporters. This difference of opinion may be related to a perceived threat to the existence of intensive care services in district general hospitals or perhaps anxieties about the practicalities of transferring patients in such a system. Similar opinions were identified in a US survey, with the majority of those that believe they would be net receivers of patients agreeing that regionalisation would improve survival and a minority of those that believed they would be net senders of patients agreeing. 12 Those with no experience of adult ECMO were more likely to believe the results of the CESAR trial and that the currently available evidence base supported ECMO, than those that worked in potential ECMO units or who had ECMO experience. This is somewhat surprising and suggests that perhaps the evidence has come under greater scrutiny from those who are more closely involved with delivering ECMO.
Strengths and limitations
To our knowledge, this is the first such survey of clinicians' opinions on the use of ECMO in clinical practice and on regionalisation of ICU services in the UK. Only members of the UK ICS were asked to participate in this survey. While this is likely to be broadly representative of UK intensive care clinicians, it is not comprehensive, and some UK intensive care clinicians will not have been asked to participate. The overall response rate was 32.7% with replies from 691 practising clinicians, making it a large survey of practice. However, the demographics of the non-respondents are not known and it is possible that their opinions on these subjects differ significantly from those who completed the survey. Twenty percent of respondents to this survey report personal experience of ECMO in their unit; given that there are approximately two hundred ICUs in the UK this suggests that those that work in units that have delivered ECMO are overrepresented as respondents to this survey.
Although the majority of respondents were medical, we did intentionally survey non-medical members of the society including nurses and other healthcare practitioners. Therefore the results do, in part, reflect the opinions of these healthcare practitioners' views who could have different perspectives from doctors on these issues.
Conclusions
Intensive care clinicians in the UK support an expansion of ECMO services for adults with severe acute respiratory failure. However, there is a broad spectrum of opinion regarding the quality and definitive nature of this evidence base for the use of ECMO in adults. If an expanded adult ECMO service is envisaged, clinicians support appropriate funding, training and transport infrastructure, and the development of a national guideline. 
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